Answers are grounded in this paper and cite their sources.
Background Aspartate aminotransferase/alanine aminotransferase (AST/ALT) ratio has been shown to be associated with type 2 diabetes and its complications. The aim of this paper is to investigate the relationship between AST/ALT ratio and hyperuricemia in a type 2 diabetes population. Methods There were 1997 subjects, 597 of whom had hyperuricemia. Multivariate binary logistic regression analysis was applied to explore the correlation between AST/ALT ratio and hyperuricemia. Stratified by gender and body mass index (BMI), the predictive value of different subgroups was compared. Results The risk of hyperuricemia in patients with type 2 diabetes mellitus (T2DM) is negatively correlated with AST/ALT ratio. In unadjusted models, each standard deviation (SD) increase in AST/ALT ratio was associated with a 64% reduction in the risk of hyperuricemia (95% CI: 0.27,0.48; P < 0.001). After adjusting for sex, gender, body mass index (BMI), fasting blood glucose (FBG) and glycosylated hemoglobin (HbA1c), the adjusted odds ratio (OR) and 95% confidence interval (CI) of model 4 was 0.54 (0.35,0.82). Conclusion AST/ALT ratio is associated with the risk of hyperuricemia in patients with T2DM, especially in overweight and young adults.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: